Duration of effect of single-dose inhaled fluticasone propionate on AMP‐induced bronchoconstriction
Authors:
- R.D. KempsfordRKR.D. Kempsford
- A.M. WrightAWA.M. Wright
- P. ZanenPZP. Zanen
- J-W.J. LammersJLJ-W.J. Lammers
- 1 April 2004
- journal article
- clinical trial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 23 (4) , 559-564
Abstract
Airway hyperresponsiveness induced by adenosine‐5'‐monophosphate (AMP) is regarded as a reliable model for allergic asthma and for the evaluation of anti-asthmatic drugs. Single-dose inhaled corticosteroids (ICS) are known to be protective in this model, but the duration of action of these drugs in this model has never been studied.The duration of ICS protection was determined by administration of single-dose fluticasone propionate (FP; 1,000 µg) up to 26 h before AMP challenge. A randomised, double-blind, placebo-controlled, four-way crossover study was performed in 13 mild asthmatics (mean±sd predicted forced expiratory volume in one second (FEV1) 98±7%). Each subject received placebo and FP (at 26, 14 or 2 h prior to the AMP challenge). Furthermore, the marker exhaled nitric oxide (eNO) was studied after administration at these time points to investigate whether eNO also demonstrates the duration of action of ICS.The doubling concentrations difference (DCD) of AMP causing a 20% fall in FEV1, when FP was administered 26, 14 or 2 h prior to challenge, was significantly increased as compared with placebo: DCD (95% confidence interval) at 26 h, 0.73 (0.20–1.26), p=0.008; 14 h, 1.50 (0.99–2.01), p<0.001; and 2 h, 2.89 (2.37–3.40), p<0.001. However, eNO was not significantly affected at these time points.In conclusion, a single dose of 1,000 µg inhaled fluticasone propionate protects against adenosine‐5'‐monophosphate airway hyperresponsiveness up to 26 h after dosing. This study suggests that adenosine‐5'‐monophosphate challenge can be used as a sensitive marker to study the duration of action of inhaled corticosteroids.Keywords
This publication has 25 references indexed in Scilit:
- Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammationJournal of Allergy and Clinical Immunology, 2002
- Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthmaJournal of Allergy and Clinical Immunology, 2002
- Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Corticosteroid-induced Improvement in the PC20 of Adenosine Monophosphate Is More Closely Associated with Reduction in Airway Inflammation than Improvement in the PC20 of MethacholineAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Acute Anti-inflammatory Effects of Inhaled Budesonide in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Clinical aspects of exhaled nitric oxideEuropean Respiratory Journal, 2000
- Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical researchEuropean Respiratory Journal, 2000
- Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children—1999: This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999American Journal of Respiratory and Critical Care Medicine, 1999
- References values for forced spirometry. Group of the European Community Respiratory Health SurveyEuropean Respiratory Journal, 1998
- Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adultsEuropean Respiratory Journal, 1993